News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Insider Information

Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million

Epigenomics AG / Key word(s): Bond/FinancingEpigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million 11-Jun-2021 / 21:05 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]

Read more

Epigenomics AG successfully completes capital increase

Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG successfully completes capital increase 18-May-2021 / 08:51 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT FOR PUBLICATION, DISTRIBUTION […]

Read more

Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders

Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders 27-Apr-2021 / 17:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]

Read more

Epigenomics AG is Evaluating M&A Options

Epigenomics AG / Key word(s): Strategic Company DecisionEpigenomics AG is Evaluating M&A Options 25-March-2021 / 10:48 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT TO BE […]

Read more

Epigenomics AG successfully places mandatory convertible bond in the full amount of EUR 5.5 million

Epigenomics AG / Key word(s): Bond/Issue of DebtEpigenomics AG successfully places mandatory convertible bond in the full amount of EUR 5.5 million 27-Jan-2021 / 20:11 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]

Read more

U.S. Centers for Medicare & Medicaid Services publish negative NCD for Epi proColon

Epigenomics AG / Key word(s): MiscellaneousU.S. Centers for Medicare & Medicaid Services publish negative NCD for Epi proColon 20-Jan-2021 / 00:02 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of […]

Read more